InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,444.80
(
2.16%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
62,793.43
(
6.22%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

steeledge

Send PM Follow Ignore
Followers 77
Posts 3440
Boards Moderated 0
Alias Born 02/11/2004

steeledge

Member Level

Re: None

Tuesday, 07/14/2015 1:39:29 PM

Tuesday, July 14, 2015 1:39:29 PM

Post# of 97237
OPGN Merck invests $6M into OPGN @ $4.40; stock at 3.99. OPGN then buys AdvanDX, in whom Merck is also an investor.

Sounds like MRK wants MRSA exposure.

Deal w/ MRK:
http://finance.yahoo.com/news/opgen-closes-6-million-financing-130500363.html

Acquisition of AdvanDX:
http://finance.yahoo.com/news/opgen-acquire-advandx-inc-130113225.html

Yesterday's news with Fluidigm:
http://finance.yahoo.com/news/fluidigm-opgen-enter-strategic-agreement-160000564.html

2.9M share IPO back in May was a dog, but newsflow right now is good.

Solid DD combined with timeliness and conviction is a recipe for profits.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up